KALV
KalVista Pharmaceuticals, Inc. · Healthcare
CEO Benjamin L Palleiko sold $53K of KalVista Pharmaceuticals, Inc.
Sold$52,658
$15.70Price
3,354Shares
−1%Stake
What KALV did after the filing
- The stock from Tue, Feb 17 open, $14.82
- +35.8%
- S&P 500, same days
- −4.4%
Measured over 30 trading days, to the Mar 31 close.
Traded Thu, Feb 12. Filed Fri, Feb 13, 4:05 PM ET, after the close. Returns use the Feb 17 open and the Mar 31 close. Not investment advice.